Document Report Card

Basic Information

ID: ALA3751835

Journal: Bioorg Med Chem Lett

Title: Discovery of the imidazole-derived GPR40 agonist AM-3189.

Authors: Ma Z, Lin DC, Sharma R, Liu J, Zhu L, Li AR, Kohn T, Wang Y, Liu JJ, Bartberger MD, Medina JC, Zhuang R, Li F, Zhang J, Luo J, Wong S, Tonn GR, Houze JB.

Abstract: As a follow-up to the GPR40 agonist AMG 837, which was evaluated in clinical trials for the treatment of type II diabetes, further optimization led to the discovery of AM-3189 (13k). AM-3189 is representative of a new class of compounds with minimal CNS penetration, superior pharmacokinetic properties and in vivo efficacy comparable to AMG 837.

CiteXplore: 26620255

DOI: 10.1016/j.bmcl.2015.11.050